Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages

  Blomqvist, Maria ^a   Osterbye, Thomas ^b   Månsson, Jan Eric ^a   Buschard, Karsten ^b   Fredman, Pam ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLYCOSPHINGOLIPID; SULFATIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL ISOLATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HYDROXYLATION; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL TRACT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PROTEIN DEGRADATION; RAT; SCINTILLATION COUNTING; SMALL INTESTINE; THIN LAYER CHROMATOGRAPHY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT; ENDOCYTOSIS; GASTROINTESTINAL TRACT; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED BALB C; MICE, OBESE; OBESITY; PANCREAS; PROTEIN ISOFORMS; RATS; RATS, INBRED LEW; SULFOGLYCOSPHINGOLIPIDS;

MAMMALIA;

EID: 33750375606     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-26     Document Type: Article

References (46)

1. Ishizuka I: Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 1997, 36:245-319.
2. Buschard K, Josefsen K, Horn T, Larsen S, Fredman P: Sulphatide antigen in islets of Langerhans and in diabetic glomeruli, and anti-sulphatide antibodies in type 1 diabetes mellitus. APMIS 1993, 101:963-970.
3. Blomqvist M, Osterbye T, Månsson JE, Horn T, Buschard K, Fredman P: Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models. APMIS 2003, 111:867-877.
4. Buschard K, Schloot NC, Kaas A, Bock T, Horn T, Fredman P, Roep BO: Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cells. Diabetologia 1999, 42:1212-1218.
5. Ding Z, Kawashima H, Miyasaka M: Sulfatide binding and activation of leukocytes through an L-selectin- independent pathway. J Leukoc Biol 2000, 68:65-72.
6. Frier Bovin L, Fredman P, Månsson JE, Buschard K, Bendtzen K: In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide. FEBS Lett 1999, 455:339-343.
7. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V: Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 2004, 199:947-957.
8. Roeske-Nielsen A, Fredman P, Mansson JE, Bendtzen K, Buschard K: Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. Immunol Lett 2004, 91:205-211.
9. Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G: Presentation of the same glycolipid by different CD1 molecules. J Exp Med 2002, 195:1013-1021.
10. Fredman P, Månsson JE, Rynmark BM, Josefsen K, Ekblond A, Halldner L, Osterbye T, Horn T, Buschard K: The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling; possible involvement in insulin trafficking. Glycobiology 2000, 10:39-50.
11. Osterbye T, Jorgensen KH, Fredman P, Tranum-Jensen J, Kaas A, Brange J, Whittingham JL, Buschard K: Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. Glycobiology 2001, 11:473-479.
12. Buschard K, Hoy M, Bokvist K, Olsen HL, Madsbad S, Fredman P, Gromada J: Sulfatide controls insulin secretion by modulation of ATP-sensitive K+-channel activity and Ca2+-dependent exocytosis in rat pancreatic beta-cells. Diabetes 2002, 51:2514-2521.
13. Hsu FF, Bohrer A, Turk J: Electrospray ionization tandem mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species expressed in brain and in pancreatic islets. Biochim Biophys Acta 1998, 1392:202-216.
14. Kannagi R, Nudelman E, Hakomori S: Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A 1982, 79:3470-3474.
15. Kannagi R, Stroup R, Cochran NA, Urdal DL, Young WW Jr., Hakomori S: Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res 1983, 43:4997-5005.
16. Lingwood CA: Aglycone modulation of glycolipid receptor function. Glycoconj J 1996, 13:495-503.
17. Mamelak D, Mylvaganam M, Whetstone H, Hartmann E, Lennarz W, Wyrick PB, Raulston J, Han H, Hoffman P, Lingwood CA: Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members. Biochemistry 2001, 40:3572-3582.
18. Blomqvist M, Carrier M, Andrews T, Pettersson K, Månsson JE, Rynmark BM, Fredman P, Buschard K: In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose stimulated insulin secretion in Zucker fatty (fa/fa) rats. Diabetes Metab Res Rev 2005, 21:158-166.
19. Buschard K, Blomqvist M, Månsson JE, Fredman P, Juhl K, Gromada J: C16:0 sulfatide inhibits insulin secretion in rat beta cells by reducing ATP-sensitive K+ channels to ATP inhibition. Diabetes 2006, 55(10):2826-2834.
20. Nilsson A: Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim Biophys Acta 1968, 164:575-584.
21. Nilsson A: Metabolism of cerebroside in the intestinal tract of the rat. Biochim Biophys Acta 1969, 187:113-121.
22. Schmelz EM, Crall KJ, Larocque R, Dillehay DL, Merrill AH Jr.: Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J Nutr 1994, 124:702-712.
23. Natomi H, Sugano K, Iwamori M, Takaku F, Nagai Y: Region-specific distribution of glycosphingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid. Biochim Biophys Acta 1988, 961:213-222.
24. Iwamori M, Suzuki H, Ito N, Iwamori Y, Hanaoka K: Lipid compositions of human gastric fluid and epithelium: the role of sulfated lipids in gastric cytoprotection. J Clin Gastroenterol 2005, 39:129-133.
25. Breimer ME, Hansson GC, Karlsson KA, Leffler H: The preparative separation of sialic acid-containing lipids from sulphate group-containing glycolipids from small intestine of different animals. Analysis by thin-layer chromatography and detection of novel species. J Biochem (Tokyo) 1983, 93:1473-1485.
26. Natomi H, Sugano K, Takaku F, Iwamori M: Glycosphingolipid composition of the gastric mucosa. A role of sulfatides in gastrointestinal mucosal defense? J Clin Gastroenterol 1990, 12 Suppl 1:S52-7.
27. Natomi H, Saitoh T, Sugano K, Iwamori M, Fukayama M, Nagai Y: Systematic analysis of glycosphingolipids in the human gastrointestinal tract: enrichment of sulfatides with hydroxylated longer-chain fatty acids in the gastric and duodenal mucosa. Lipids 1993, 28:737-742.
28. Beausoleil HE, Lepine F, Dubreuil JD: LC-MS analysis of pig intestine sulfatides: interaction with Escherichia coli STb enterotoxin and characterization of molecular species present. FEMS Microbiol Lett 2002, 209:183-188.
29. Nilsson A: The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 1969, 176:339-347.
30. Nilsson A, Duan RD: Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract. Chem Phys Lipids 1999, 102:97-105.
31. Buschard K, Josefsen K, Horn T, Fredman P: Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet 1993, 342:840.
32. Andersson K, Buschard K, Fredman P, Kaas A, Lidström AL, Madsbad S, Mortensen H, Månsson JE: Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay. Autoimmunity 2002, 35:463-468.
33. Buschard K, Hageman I, Hansen AK, Fredman P: Neonatal treatment of BB rats with sulphatide delays development of diabetes but does not change incidence. APMIS 1995, 103:193-196.
34. Buschard K, Hanspers K, Fredman P, Reich EP: Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice. Autoimmunity 2001, 34:9-17.
35. Bleicher PA, Balk SP, Hagen SJ, Blumberg RS, Flotte TJ, Terhorst C: Expression of murine CD1 on gastrointestinal epithelium. Science 1990, 250:679-682.
36. Blumberg RS, Terhorst C, Bleicher P, McDermott FV, Allan CH, Landau SB, Trier JS, Balk SP: Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol 1991, 147:2518-2524.
37. van de Wal Y, Corazza N, Allez M, Mayer LF, Iijima H, Ryan M, Cornwall S, Kaiserlian D, Hershberg R, Koezuka Y, Colgan SP, Blumberg RS: Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 2003, 124:1420-1431.
38. Chatelut M, Leruth M, Harzer K, Dagan A, Marchesini S, Gatt S, Salvayre R, Courtoy P, Levade T: Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue. FEBS Lett 1998, 426:102-106.
39. Perry DK, Hannun YA: The role of ceramide in cell signaling. Biochim Biophys Acta 1998, 1436:233-243.
40. Rosengren B, Fredman P, Månsson JE, Svennerholm L: Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J Neurochem 1989, 52:1035-1041.
41. Svennerholm L, Håkansson G, Månsson JE, Vanier MT: The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta 1979, 92:53-64.
42. Fredman P, Mattsson L, Andersson K, Davidsson P, Ishizuka I, Jeansson S, Månsson JE, Svennerholm L: Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem J 1988, 251:17-22.
43. Schwarzmann G: A simple and novel method for tritium labeling of gangliosides and other sphingolipids. Biochim Biophys Acta 1978, 529:106-114.
44. Buschard K, Aaen K, Horn T, Van Damme J, Bendtzen K: Interleukin 6: a functional and structural in vitro modulator of beta- cells from islets of Langerhans. Autoimmunity 1990, 5:185-194.
45. Svennerholm L, Fredman P: A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 1980, 617:97-109.
46. Davidsson P, Fredman P, Månsson JE, Svennerholm L: Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. Clin Chim Acta 1991, 197:105-115.